ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
10.38
-0.62 (-5.64%)
At close: Jul 2, 2026, 4:00 PM EDT
10.29
-0.09 (-0.87%)
After-hours: Jul 2, 2026, 4:10 PM EDT
ImmuCell Market Cap
ImmuCell has a market cap or net worth of $93.09 million as of July 2, 2026. Its market cap has increased by 62.83% in one year.
Market Cap
93.09M
Enterprise Value
99.06M
1-Year Change
62.83%
Ranking
Category
Stock Price
$10.38
Market Cap Chart
Since May 1, 1992, ImmuCell's market cap has increased from $1.99M to $93.09M, an increase of 4,573.27%. That is a compound annual growth rate of 11.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 93.09M | 67.33% |
| Dec 31, 2025 | 55.63M | 21.22% |
| Dec 31, 2024 | 45.89M | 16.33% |
| Dec 29, 2023 | 39.45M | -16.51% |
| Dec 30, 2022 | 47.26M | -23.70% |
| Dec 31, 2021 | 61.94M | 44.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pelthos Therapeutics | 96.03M |
| Alps Group | 94.85M |
| Adicet Bio | 91.67M |
| Rein Therapeutics | 90.99M |
| Lixte Biotechnology Holdings | 90.40M |
| MAIA Biotechnology | 89.07M |
| Cardiff Oncology | 88.88M |
| Telomir Pharmaceuticals | 88.72M |